THE PRODUCTION OF METHEMOGLOBIN BY PNEUMOCOCCI

R Cole1

  • 1Hospital of The Rockefeller Institute for Medical Research.

Insights

Living pneumococci bacteria convert hemoglobin to methemoglobin, a process requiring oxygen and often facilitated by sugars like dextrose. This finding offers insights into bacterial pathogenesis.

Area of Science:

  • Microbiology
  • Biochemistry
  • Pathogenesis

Background:

  • Pneumococci are known to interact with host molecules.
  • Methemoglobin formation is a biochemical process with implications for oxygen transport.

Purpose of the Study:

  • To investigate the mechanism by which pneumococci induce methemoglobin formation.
  • To elucidate the role of co-factors and environmental conditions in this reaction.

Main Methods:

  • Incubation of pneumococci with hemoglobin under varying conditions.
  • Addition of different sugars and organic substances.
  • Manipulation of oxygen levels.

Main Results:

  • Living pneumococci, but not their extracts, convert hemoglobin to methemoglobin.
  • Dextrose or other sugars significantly enhance the reaction.
  • Oxygen is essential, with its removal and reintroduction accelerating the process.

Conclusions:

  • Pneumococci-induced methemoglobin formation is an active, oxygen-dependent process.
  • The reaction likely involves oxidation-reduction mechanisms, similar to chemical methemoglobin inducers.
  • Understanding this mechanism may explain pathological effects of bacteria lacking soluble toxins.

Related Concept Videos

Oxygen Transport in the Blood01:27

Oxygen Transport in the Blood

Hemoglobin (Hb) is a crucial molecule in the human body, consisting of four polypeptide chains, each bound to an iron-containing heme group. This unique structure enables hemoglobin to bind to oxygen, with each molecule capable of combining with four molecules of oxygen, leading to rapid and reversible oxygen loading. When fully loaded with oxygen, it is called oxyhemoglobin, while hemoglobin that has released oxygen is called reduced hemoglobin or deoxyhemoglobin. As hemoglobin binds oxygen,...
Production of Antibiotics01:27

Production of Antibiotics

Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Hemoglobin01:24

Hemoglobin

Hemoglobin is a globular protein made up of four subunits. Two of these subunits are alpha chains, and the other two are beta chains. Each subunit contains a molecule of heme, which has an iron atom and can bind to oxygen. When an oxygen molecule binds to one heme group, it changes the shape of hemoglobin, making it easier for the other heme groups to bind oxygen as well.
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...